News

Venture Challenge Fall 2022 open for applications!

Curious what the Venture Challenge may bring you? This is what last year's alumni say about it.
VC foto

STENTiT raises €1.8 Million in Seed Round

Eindhoven, The Netherlands, 25 April 2022 – Venture Challenge alumnus STENTiT, a medical device company bringing a novel class of regenerative endovascular implants for the treatment of cardiovascular diseases, has closed a €1.8 million see
Stentit seed round

Ncardia launches Cellistic, an iPSC cell therapy CDMO

Ncardia launches CellisticTM, the only iPSC-based cell therapy process development & manufacturing partner purpose-built to make large-scale allogeneic cell therapy production a reality today.
Cellestic

Life Sciences & Health Krijgt Boost na Gehonoreerde Groeifonds Voorstellen!

Een investering van € 5 miljard en daarnaast een reservering van € 1,3 miljard voor in totaal 28 projecten moeten zorgen voor duurzame economische groei in Nederland.
Life Sciences & Health Krijgt Boost na Gehonoreerde Groeifonds Voorstellen!

Expert class ‘Business and Sales Development’ review

On the 18th of March, Iventus and LifeSciences@Work had the honor to host the second expert class of this year.
Expert class ‘Business and Sales Development’ review

Protinhi Therapeutis secures €1.7mln Eurostars subsidy

Venture Challenge alumnus Protinhi Therapeutics was awarded the most innovative Eurostars project in The Netherlands in 2022.
Eurostars

You can now express your interest in IPCEI Health!

IPCEI stands for Important Projects of Common European Interest.
You can now express your interest in IPCEI Health!

Een primeur in de geschiedenis van de Nationale Zorginnovatieprijs: Helpsoq wint zowel de vakjury- als de publieksprijs!

De innovatie Helpsoq is unaniem uitgeroepen tot de winnaar van de Nationale Zorginnovatieprijs 2022. Tijdens de uitreiking op het Health Valley Event werd Helpsoq aangekondigd als winnaar van zowel de vakjuryprijs ter waarde van €10.000,- als de publieksprijs ter waarde van €5.000,-. Een unicum in de geschiedenis van deze prijs.
Winner

Venture Challenge Alumnus Bi/ond has closed over $4+ Million in funding to date led by FORWARD.one

Organ-on-a-chip succes with leading European research institutioins fuels Bi/ond Investment.
Research

Venture Challenge Alumnus TargED raises €39 million in a series A investment round

TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking thrombolytic treatment to patients.
Venture Challenge Alumnus TargED raises €39 million in a series A investment round